ATE228374T1 - Arzneiverabreichungssystem - Google Patents

Arzneiverabreichungssystem

Info

Publication number
ATE228374T1
ATE228374T1 AT94918945T AT94918945T ATE228374T1 AT E228374 T1 ATE228374 T1 AT E228374T1 AT 94918945 T AT94918945 T AT 94918945T AT 94918945 T AT94918945 T AT 94918945T AT E228374 T1 ATE228374 T1 AT E228374T1
Authority
AT
Austria
Prior art keywords
matrix
drug
drug administration
administration system
receptor
Prior art date
Application number
AT94918945T
Other languages
English (en)
Inventor
Margaret Joan Taylor
Original Assignee
Univ Montfort
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montfort filed Critical Univ Montfort
Application granted granted Critical
Publication of ATE228374T1 publication Critical patent/ATE228374T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
AT94918945T 1993-06-30 1994-06-27 Arzneiverabreichungssystem ATE228374T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939313484A GB9313484D0 (en) 1993-06-30 1993-06-30 Drug system ii
PCT/GB1994/001384 WO1995001186A1 (en) 1993-06-30 1994-06-27 Drug system

Publications (1)

Publication Number Publication Date
ATE228374T1 true ATE228374T1 (de) 2002-12-15

Family

ID=10738039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918945T ATE228374T1 (de) 1993-06-30 1994-06-27 Arzneiverabreichungssystem

Country Status (11)

Country Link
US (2) US5902607A (de)
EP (1) EP0706401B1 (de)
JP (1) JP4572008B2 (de)
AT (1) ATE228374T1 (de)
AU (1) AU7004194A (de)
DE (1) DE69431800T2 (de)
DK (1) DK0706401T3 (de)
ES (1) ES2185654T3 (de)
GB (1) GB9313484D0 (de)
PT (1) PT706401E (de)
WO (1) WO1995001186A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system
GB0116860D0 (en) * 2001-07-10 2001-09-05 Univ Montfort Gel compositions
US7531191B2 (en) * 2002-12-17 2009-05-12 Massachusetts Institute Of Technology Stimuli-responsive systems for controlled drug delivery
GB0412631D0 (en) * 2004-06-07 2004-07-07 Cambridge Applied Polymers Ltd Polymer release system
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
WO2007047997A2 (en) 2005-10-19 2007-04-26 Smartcells, Inc. Methods for reducing the mitogenicity of lectin compositions
EP2117601A2 (de) * 2006-12-22 2009-11-18 The Regents of the University of California Makromolekulare konjugate von zystische-fibrose-transmembran-leitwert-regulatorprotein-inhibitoren und verwendungen davon
AU2010208295A1 (en) * 2009-01-28 2011-08-04 Smartcells, Inc. Polynucleotide aptamer-based cross -linked materials and uses thereof
PE20120582A1 (es) 2009-01-28 2012-05-26 Smartcells Inc Conjugados de insulina cristalina
WO2010088286A1 (en) 2009-01-28 2010-08-05 Smartcells, Inc. Synthetic conjugates and uses thereof
AU2010208381A1 (en) 2009-01-28 2011-08-04 Smartcells, Inc. Exogenously triggered controlled release materials and uses thereof
SG173112A1 (en) 2009-01-28 2011-08-29 Smartcells Inc Conjugate based systems for controlled drug delivery
WO2010107520A1 (en) 2009-03-20 2010-09-23 Smartcells, Inc. Soluble non-depot insulin conjugates and uses thereof
EP2408808A4 (de) * 2009-03-20 2015-05-06 Smartcells Inc Terminal-funktionalisierte konjugate und ihre verwendung
US9095623B2 (en) * 2009-03-20 2015-08-04 Smartcells, Inc. Terminally-functionalized conjugates and uses thereof
CA2806399A1 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Recombinantly expressed insulin polypeptides and uses thereof
EP2598522A4 (de) 2010-07-28 2014-11-12 Smartcells Inc Rekombinante lektine, bindungsstellenmodifizierte lektine und anwendungen davon
CA2805739A1 (en) 2010-07-28 2012-02-02 Smartcells, Inc. Drug-ligand conjugates, synthesis thereof, and intermediates thereto
CA2902256A1 (en) * 2012-02-17 2013-08-22 Massachusetts Institute Of Technology Self-regulated peptide hydrogel for insulin delivery
GB201310185D0 (en) 2013-06-07 2013-07-24 Univ Montfort Container
GB201314640D0 (en) 2013-08-15 2013-10-02 Univ Montfort Matrix gel
WO2015051052A2 (en) 2013-10-04 2015-04-09 Merck Sharp & Dohme Corp. Glucose-responsive insulin conjugates
US11041009B2 (en) 2017-03-23 2021-06-22 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
US11820805B2 (en) 2017-12-18 2023-11-21 Merck Sharp & Dohme Llc Conjugate based systems for controlled insulin delivery
US11413352B2 (en) 2017-12-18 2022-08-16 Merck, Sharp & Dohme LLC Conjugate based systems for controlled insulin delivery
CN108721605B (zh) * 2018-06-01 2022-10-14 华南师范大学 一种装载有胰岛素的纳米粒子及其应用
US20230010871A1 (en) * 2019-12-13 2023-01-12 Folium Labs Inc. Complexes comprising a carbohydrate polymer and an active ingredient and processes for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348387A (en) * 1979-07-31 1982-09-07 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
IE921050A1 (en) * 1991-04-02 1992-10-07 Biotech Australia Pty Ltd Oral delivery systems for microparticles
GB9200638D0 (en) * 1992-01-10 1992-03-11 Leicester Polytechnic Drug system

Also Published As

Publication number Publication date
US5902607A (en) 1999-05-11
EP0706401B1 (de) 2002-11-27
DE69431800D1 (de) 2003-01-09
ES2185654T3 (es) 2003-05-01
AU7004194A (en) 1995-01-24
JPH09501416A (ja) 1997-02-10
DE69431800T2 (de) 2003-09-04
EP0706401A1 (de) 1996-04-17
WO1995001186A1 (en) 1995-01-12
US6410053B1 (en) 2002-06-25
GB9313484D0 (en) 1993-08-11
PT706401E (pt) 2003-03-31
DK0706401T3 (da) 2003-03-03
JP4572008B2 (ja) 2010-10-27

Similar Documents

Publication Publication Date Title
DE69431800D1 (de) Arzneiverabreichungssystem
US5656284A (en) Oral transmucosal delivery tablet and method of making it
ATE122879T1 (de) Verabreichungsformen für pharmaka.
CS9004859A2 (en) Method of adhesive plaster production that contains oestrogen as active substance
WO2003077972A3 (en) Implantable drug delivery system
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
BR9608542A (pt) Composição para a liberação sustentada de hormónio do crescimento humano
DE69508938T2 (de) Transdermales arzneistoff-abgabesystem
IE860306L (en) Drug delivery system
ATE516049T1 (de) Formulierung zur gesteuerten arzneistofffreisetzung durch kombination hydrophiler und hydrophober stoffe
ATE59302T1 (de) Klebende schicht zur transdermalen freigabe.
FI960556A0 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
ATE143257T1 (de) Arzneiabgabesystem, verfahren zu dessen herstellung sowie dessen verwendung
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
EP0325086A3 (de) Verfahren zur Herstellung von therapeutischen Systemen mit gesteuerter Freigabe des Wirkstoffes
CA1269326C (en) ADHESIVE LAYER FOR TRANDERMAL ADMINISTRATION OF DRUGS

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0706401

Country of ref document: EP